logo

Jounce Therapeutics, Inc. (JNCE)



Trade JNCE now with
  Date
  Headline
11/13/2017 6:34:51 AM Jounce Therapeutics Q3 Net Loss $4.1 Mln Or $0.13/Shr Vs Income Of $4.1 Mln Or $0.07/Shr Last Year
8/15/2017 8:03:49 AM Jounce Therapeutics Names Hugh Cole As Chief Business Officer And Head Of Corporate Development
8/9/2017 6:37:10 AM Jounce Therapeutics Q2 Net Loss $3.4 Mln Or $0.11/Shr Vs $12.3 Mln Or $7.23/Shr Last Year
5/9/2017 8:02:36 AM Jounce Therapeutics Posts Q1 Net Income Of $0.4 Mln Or $0.02/share
3/10/2017 8:06:52 AM Jounce Therapeutics Q4 Net Income $5.5 Mln Vs. Net Loss $10.1 Mln Last Year
  
 
>